Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-28 21:58:23 - browse：3

Stacks of silver coins surrounded by a medicare health insurance card — insurance coverage from STAT — A federal rule that could make Medicare reimbursement for breakthrough devices easier is slated for early summer. Adobe

WASHINGTON — A federal rule aiming to make reimbursement for breakthrough devices easier is slated for early summer, a Centers for Medicare and Medicaid Services official said on Thursday.

The agency has faced intense pressure from device makers frustrated with the slow pace of Medicare reimbursement decisions. Medical technology lobby AdvaMed sent CMS a strongly-worded letter in March asking why it has taken so long to get the breakthrough device program moving.

Dora Hughes, director of the clinical standards center at CMS, told attendees at the Medical Device Manufacturers’ Association conference the agency wanted to take the time to meaningfully address feedback sent during the comment period, which closed in August. She also noted the organization’s goal of releasing the final rule with a slate of other policies, including a rule clarifying the agency’s thinking on what kind of evidence would be needed to convince the agency that a given device is both reasonable and necessary.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Kenai launches with $82 million for Parkinson’s stem cell therapy

WSS

How climate

ALS groups 'won't be played again' by the FDA, drug sponsors

2023 STAT Wunderkinds: get to know the winners

FDA does about

AstraZeneca loses challenge to Medicare drug price negotiation

How to fix the rural physician shortage in the U.S.

focus

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Obesity now affects over 1 billion people worldwide, study finds

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Summit: GSK CEO on pharma giant's new direction

In age of alternative facts, a scholarly course on calling out crap

An inside look at PIPEs, biotech's buzzy new financing tool

Cancer drug shortages should be causing more outrage

The EU Joint Clinical Assessment needs to live up to its promise

FDA approval of Sarepta Duchenne genetic therapy gives me hope

HHS leader on health, climate change and biopharma emissions

hotspot

FDA gives detailed accounting of AI

Why health workers in Gaza are injured or die at high rates

Flu vaccine offering decent levels of protection this winter, new data show

STAT Summit: Biotech founders on deal

House looks to weaken Medicare negotiation

A Q&A with Aletha Maybank, AMA’s chief health equity officer

leisure time

hotspot

explore

knowledge